ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies Ltd. (IPA), an AI-driven biotherapeutic research and technology company, is scheduled to release its full year financial results and business highlights for fiscal year 2024 on July 25th, 2024, along with hosting an earnings conference call that same day. The call will be accessible via a live audio webcast on IPA’s Investor Relations website, with a replay available afterwards. IPA specializes in advanced antibody discovery and biologics development, offering out-licensing and partnering opportunities in biopharmaceutical research.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
